Steven Mintz - 08 Jan 2024 Form 3 Insider Report for AgeX Therapeutics, Inc. (SER)

Role: Director
Signature: /s/ Steven Mintz
Issuer symbol: SER
Transactions as of: 08 Jan 2024
Net transactions value: $0
Form type: 3
Filing time: 18 Jan 2024, 17:29:46 UTC
Next filing: 03 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	AGE	Common Stock, $0.0001 par value						116,324	08 Jan 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	AGE	Option to Purchase Common Stock							08 Jan 2024	Common Stock	63,756	$0.3750	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held in joint accounts with adult children.
F2	Stock options will vest in quarterly installments based upon Mr. Mintz's continued service as a director, with options to purchase 15,006 shares scheduled to vest on March 31,2024 and options to purchase 16,250 shares scheduled to vest on each of the following dates: June 30, 2024, September 30, 2024, and December 31, 2024.